Glaukos Corp.
Large Cap · Healthcare · Medical Devices
$184.17−$1.45 (-0.78%)
Glaukos Corp.
Large Cap · Healthcare · Medical Devices
$184.17−$1.45 (-0.78%)
Stock analysis
Get the AI take on GKOS
Track it to unlock the price chart, verdict and what could change it.
- ✓Live price chart
- ✓A clear accumulate, trim or avoid call
Free to track. No card required.
Stock Fundamentals & Key Indicators
52-week range
Low$73.16
High$166.00
Today $184.17
RSI (14)
78.7Overbought
03070100
Overall score
49/100
See the full financial picture
Open the five-year record, valuation checks and Wall Street view behind these scores.
- ✓5 years of revenue, profit and cash flow
- ✓Valuation and balance-sheet checks
- ✓Business and geographic mix
- ✓Analyst targets and recommendation trend
Free for 3 days, then $9/mo. Cancel anytime.
Analyst Rating and Sentiment
Analyst price targets
Lowest
$172
Current price
$184.17
Median target
$193
Highest
$215
LowHigh
Operating Record
Revenue
What's working
- Cash exceeds debt by $178.6M, leaving a net cash buffer, a good sign.
- Debt / equity: Light borrowing means a rough patch wouldn't threaten the balance sheet.
What to watch
- Forward P/E: The price already assumes strong earnings growth that still has to show up.
- Price / sales: Revenue alone can't justify this price; profits need to catch up fast.
What the market charges
Forward P/E
Needs attention · 1724% above avg
1783.09x
Price / sales
Rich · Priced well above what its revenue alone supports
17.75x
Price / FCF
No signal · Not enough data to judge
-
EV / EBITDA
No signal · Not enough data to judge
-
How efficiently it compounds
ROIC
Weak · Struggling to earn much on the capital it uses
-15.7%
ROE
Needs attention · Unfavorable
-26.0%
Debt / equity
Favorable · 0.15 - strong leverage
0.16x
Current ratio
Strong · Comfortable room to cover bills due within a year
5.04x
Peer Comparison
| Company | Mkt cap | P/E | Rev growth | Score |
|---|---|---|---|---|
| $10.88B | - | +41.5% | 49 |
 | $11.53B | 22.0 | +19.7% | 78 |
 | $4.60B | 13.9 | +13.5% | 77 |
 | $33.87B | 35.4 | +15.5% | 77 |
 | $1.11T | 40.1 | +49.6% | 76 |